156 related articles for article (PubMed ID: 19946803)
1. Problems meeting basic needs moderate the association between the APOE epsilon4 allele and cognitive decline.
Sachs-Ericsson N; Corsentino E; Collins N; Sawyer K; Blazer DG
Aging Ment Health; 2010 Mar; 14(2):138-44. PubMed ID: 19946803
[TBL] [Abstract][Full Text] [Related]
2. Cognitive impairment and the role of the ApoE epsilon4-allele after stroke--a 13 months follow-up study.
Wagle J; Farner L; Flekkøy K; Wyller TB; Sandvik L; Eiklid KL; Fure B; Stensrød B; Engedal K
Int J Geriatr Psychiatry; 2010 Aug; 25(8):833-42. PubMed ID: 19960482
[TBL] [Abstract][Full Text] [Related]
3. Depressive symptoms moderate the influence of the apolipoproteine epsilon4 allele on cognitive decline in a sample of community dwelling older adults.
Corsentino EA; Sawyer K; Sachs-Ericsson N; Blazer DG
Am J Geriatr Psychiatry; 2009 Feb; 17(2):155-65. PubMed ID: 19155747
[TBL] [Abstract][Full Text] [Related]
4. APOE epsilon4 allele carriers: Biological, psychological, and social variables associated with cognitive impairment.
Sachs-Ericsson NJ; Sawyer KA; Corsentino EA; Collins NA; Blazer DG
Aging Ment Health; 2010 Aug; 14(6):679-91. PubMed ID: 20686979
[TBL] [Abstract][Full Text] [Related]
5. Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease.
Hoyt BD; Massman PJ; Schatschneider C; Cooke N; Doody RS
Arch Neurol; 2005 Mar; 62(3):454-9. PubMed ID: 15767511
[TBL] [Abstract][Full Text] [Related]
6. Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment.
Caselli RJ; Reiman EM; Locke DE; Hutton ML; Hentz JG; Hoffman-Snyder C; Woodruff BK; Alexander GE; Osborne D
Arch Neurol; 2007 Sep; 64(9):1306-11. PubMed ID: 17846270
[TBL] [Abstract][Full Text] [Related]
7. Association between ApoE epsilon4 and cognitive impairment after stroke.
Wagle J; Farner L; Flekkøy K; Wyller TB; Sandvik L; Eiklid KL; Fure B; Stensrød B; Engedal K
Dement Geriatr Cogn Disord; 2009; 27(6):525-33. PubMed ID: 19494491
[TBL] [Abstract][Full Text] [Related]
8. The association between delirium and the apolipoprotein E epsilon4 allele in the elderly.
van Munster BC; Korevaar JC; de Rooij SE; Levi M; Zwinderman AH
Psychiatr Genet; 2007 Oct; 17(5):261-6. PubMed ID: 17728664
[TBL] [Abstract][Full Text] [Related]
9. The apolipoprotein E epsilon4 allele is not associated with cognitive dysfunction in cardiac surgery.
Silbert BS; Evered LA; Scott DA; Cowie TF
Ann Thorac Surg; 2008 Sep; 86(3):841-7. PubMed ID: 18721571
[TBL] [Abstract][Full Text] [Related]
10. APOE ε4 is associated with exacerbation of cognitive decline in patients with multiple sclerosis.
Shi J; Tu JL; Gale SD; Baxter L; Vollmer TL; Campagnolo DI; Tyry TM; Zhuang Y; Kuniyoshi SM
Cogn Behav Neurol; 2011 Sep; 24(3):128-33. PubMed ID: 21945984
[TBL] [Abstract][Full Text] [Related]
11. Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease.
Lane R; Feldman HH; Meyer J; He Y; Ferris SH; Nordberg A; Darreh-Shori T; Soininen H; Pirttilä T; Farlow MR; Sfikas N; Ballard C; Greig NH
Pharmacogenet Genomics; 2008 Apr; 18(4):289-98. PubMed ID: 18334913
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E epsilon4 allele frequency in elderly depressed patients with and without cerebrovascular disease.
Traykov L; Bayle AC; Latour F; Lenoir H; Seux ML; Hanon O; Péquignot R; Bert P; Moulin F; Cantegreil I; Wenisch E; Batouche F; Mehrabian S; Rotrou Jd; Rigaud AS
J Neurol Sci; 2007 Jun; 257(1-2):280-3. PubMed ID: 17337010
[TBL] [Abstract][Full Text] [Related]
13. Impact of APOE status on cognitive maintenance in healthy elderly persons.
Zehnder AE; Bläsi S; Berres M; Monsch AU; Stähelin HB; Spiegel R
Int J Geriatr Psychiatry; 2009 Feb; 24(2):132-41. PubMed ID: 18615849
[TBL] [Abstract][Full Text] [Related]
14. APOE polymorphism affects episodic memory among non demented elderly subjects.
De Blasi S; Montesanto A; Martino C; Dato S; De Rango F; Bruni AC; Mari V; Feraco E; Passarino G
Exp Gerontol; 2009 Mar; 44(3):224-7. PubMed ID: 19059330
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein E epsilon4 allele and lorazepam effects on memory in high-functioning older adults.
Pomara N; Willoughby L; Wesnes K; Greenblatt DJ; Sidtis JJ
Arch Gen Psychiatry; 2005 Feb; 62(2):209-16. PubMed ID: 15699298
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein epsilon4 and neuropsychological performance in Alzheimer's disease and vascular dementia.
McGuinness B; Carson R; Barrett SL; Craig D; Passmore AP
Neurosci Lett; 2010 Oct; 483(1):62-6. PubMed ID: 20678545
[TBL] [Abstract][Full Text] [Related]
17. APOE alleles predict the rate of cognitive decline in Alzheimer disease: a nonlinear model.
Martins CA; Oulhaj A; de Jager CA; Williams JH
Neurology; 2005 Dec; 65(12):1888-93. PubMed ID: 16380608
[TBL] [Abstract][Full Text] [Related]
18. Most rapid cognitive decline in APOE epsilon4 negative Alzheimer's disease with early onset.
van der Vlies AE; Koedam EL; Pijnenburg YA; Twisk JW; Scheltens P; van der Flier WM
Psychol Med; 2009 Nov; 39(11):1907-11. PubMed ID: 19335933
[TBL] [Abstract][Full Text] [Related]
19. Cerebrovascular disease, APOE epsilon4 allele and cognitive decline in a cognitively normal population.
Qiu C; Winblad B; Fratiglioni L
Neurol Res; 2006 Sep; 28(6):650-6. PubMed ID: 16945218
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E epsilon4 and change in cognitive functioning in community-dwelling older adults.
Swan GE; Lessov-Schlaggar CN; Carmelli D; Schellenberg GD; La Rue A
J Geriatr Psychiatry Neurol; 2005 Dec; 18(4):196-201. PubMed ID: 16306239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
